Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 526,001 | 654,779 | 548,355 | 594,001 | 165,157 |
| Marketable Securities | 487,356 | 438,514 | 336,458 | 282,738 | 129,653 |
| Receivables | 199,976 | 187,150 | 197,660 | 160,822 | 165,718 |
| Inventories | 35,671 | 31,826 | 30,058 | 30,577 | 35,752 |
| TOTAL | $1,281,550 | $1,357,910 | $1,168,738 | $1,218,629 | $540,362 |
| Non-Current Assets | |||||
| PPE Net | 63,175 | 65,987 | 92,779 | 87,089 | 85,031 |
| Intangibles | 412,709 | 412,220 | 412,381 | 461,838 | 505,683 |
| Other Non-Current Assets | 84,802 | 80,238 | 115,731 | 128,142 | 128,809 |
| TOTAL | $560,686 | $558,445 | $620,891 | $677,069 | $719,523 |
| Total Assets | $1,842,236 | $1,916,355 | $1,789,629 | $1,895,698 | $1,259,885 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 257,611 | 254,997 | 227,102 | 194,314 | 105,849 |
| Accounts payable and accrued liabilities | 336,346 | 338,800 | 330,924 | 391,983 | 370,731 |
| TOTAL | $610,712 | $609,803 | $574,546 | $603,100 | $492,118 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,109,546 | 2,114,689 | 1,896,343 | 1,903,996 | 1,230,643 |
| Deferred Revenues | 0 | N/A | N/A | 801 | 1,224 |
| Other Non-Current Liabilities | 104,847 | 100,559 | 141,178 | 134,068 | 138,823 |
| TOTAL | $2,285,876 | $2,286,733 | $2,108,999 | $2,111,153 | $1,438,577 |
| Total Liabilities | $2,896,588 | $2,896,536 | $2,683,545 | $2,714,253 | $1,930,695 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 77,125 | 76,924 | 76,697 | 76,608 | 75,463 |
| Common Shares | 76 | 76 | 76 | 75 | 75 |
| Retained earnings | -3,580,987 | -3,474,333 | -3,375,154 | -3,283,578 | -3,127,786 |
| Other shareholders' equity | -4,343 | -16,498 | -5,560 | -1,285 | 9,609 |
| TOTAL | $-1,054,352 | $-980,181 | $-893,916 | $-818,555 | $-670,810 |
| Total Liabilities And Equity | $1,842,236 | $1,916,355 | $1,789,629 | $1,895,698 | $1,259,885 |